A computer analysis of hundreds of thousands of secure email messages between doctors and patients found that most doctors use language that is too complex for their patients to understand. The study also uncovered strategies some doctors use to overcome communication barriers. Experts on health literacy, as well as leading health care organizations, have advised
0 Comments
U.S. President Joe Biden speaks in the Eisenhower Executive Office Building in Washington, D.C., U.S., on Wednesday, Nov. 3, 2021. Al Drago | Bloomberg | Getty Images A federal appeals court has reinstated the Biden administration’s vaccine and testing requirement for private businesses that covers about 80 million American workers. The ruling by the 6th
0 Comments
Today, CDC released two reports in the Morbidity and Mortality Weekly Report highlighting the use of test-to-stay practices used in schools to minimize absenteeism and learning loss which can occur during traditional quarantine at home. In light of this updated data, CDC has added information on test-to-stay practices to our K-12 Transmission Science Brief and
0 Comments
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended marketing authorization for anifrolumab (Saphnelo) as an add-on treatment for adults with moderate to severe, active autoantibody-positive systemic lupus erythematosus (SLE), despite standard therapy, according to an announcement on Dec. 16. Anifrolumab, a monoclonal antibody that binds to subunit 1 of the
0 Comments
Becoming a new parent can feel overwhelming. We share seven simple tips to help you create a sustainable self-care routine while caring for a new baby No matter how much you love them, parenthood can feel pretty overwhelming. Having a baby naturally leads to a change in how we prioritise ourselves and, well, everything in
0 Comments
Margin marking before endoscopic mucosal resection (EMR) of large colorectal polyps cut the risk of recurrence by 80% when compared with traditional EMR, new data suggest. A team of researchers, led by Dennis Yang, MD, with the Center for Interventional Endoscopy at AdventHealth in Orlando, Florida, compared polyp recurrence after patients received EMR with margin
0 Comments
Why are some individuals able to use recreational drugs in a controlled way, whereas others switch to the compulsive, relapsing drug-seeking and -taking habits that characterize substance use disorder (SUD)? Despite more than six decades of extensive research, the question remains unanswered, hampering the development of targeted prevention and therapeutic strategies. Now, a new study
0 Comments
Theranos founder Elizabeth Holmes arrives to attend her fraud trial at federal court in San Jose, California, December 17, 2021. Peter DaSilva | Reuters SAN JOSE, Calif. — The 12 jurors who will decide the fate of Theranos founder Elizabeth Holmes are left to consider the testimony from 31 witnesses over three months as they
0 Comments
A Day in the Life of…Dr. Alexander MarmureanuThoracic and Cardiovascular Surgeon In this interview, we spoke to Dr. Alexander Marmureanu, a thoracic and cardiovascular surgeon, about his day-to-day role and responsibilities as well as his career highlights. What inspired your career into thoracic and cardiovascular surgery? It’s a very good question, but it started a
0 Comments
Researchers at Houston Methodist may have hit a breakthrough recently as they discovered a combination treatment that significantly improves the chances that a patient’s drug-resistant triple-negative breast cancer will respond positively to the treatment. The research team, led by Dr. Jenny Chang, director of the Cancer Center and Emily Herrmann Presidential Distinguished Chair in Cancer
0 Comments
The US Food and Drug Administration (FDA) has approved efgartigimod (Vyvgart, argenx), a first-in-class, targeted therapy for adults with generalized myasthenia gravis (gMG) who test positive for the antiacetylcholine receptor (AChR) antibody. “There are significant unmet medical needs for people living with myasthenia gravis, as with many other rare diseases,” Billy Dunn, MD, director, Office
0 Comments
Prompt action aids recovery – so here’s how to spot the early signs of this distressing condition, and where to go for help Around 80% of people who experience psychosis for the first time are aged between 16 and 30 years old. These years are pivotal for a lot of us and, although psychotic symptoms
0 Comments
Two cancer drugs and one drug to treat sickle cell disease will likely reach the European market soon, following approval recommendations from a European Medicines Agency (EMA) panel. The drugs are enfortumab vedotin (Padcev, Astellas/Seagen) for urothelial cancer, tepotinib (Tepmetko, Merck) for non-small cell lung cancer (NSCLC), and voxelotor (Oxbryta, Global Blood Therapeutics) for sickle
0 Comments